Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer
K Hammarström, L Nunes, L Mathot… - … Journal of Cancer, 2024 - Wiley Online Library
Rectal cancer poses challenges in preoperative treatment response, with up to 30%
achieving a complete response (CR). Personalized treatment relies on accurate …
achieving a complete response (CR). Personalized treatment relies on accurate …
[HTML][HTML] Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer
K Hammarström, L Nunes, L Mathot, A Mezheyeuski… - 2023 - diva-portal.org
Every year, around 2,200 individuals are diagnosed with rectal cancer in Sweden. As a
result of better tumour staging using magnetic resonance imaging (MRI), pre-operative …
result of better tumour staging using magnetic resonance imaging (MRI), pre-operative …
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer
K Hammarström, L Nunes, L Mathot… - International Journal of …, 2024 - infona.pl
Rectal cancer poses challenges in preoperative treatment response, with up to 30%
achieving a complete response (CR). Personalized treatment relies on accurate …
achieving a complete response (CR). Personalized treatment relies on accurate …
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer
K Hammarström, L Nunes, L Mathot… - … journal of cancer, 2024 - pubmed.ncbi.nlm.nih.gov
Rectal cancer poses challenges in preoperative treatment response, with up to 30%
achieving a complete response (CR). Personalized treatment relies on accurate …
achieving a complete response (CR). Personalized treatment relies on accurate …
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer.
K Hammarström, L Nunes, L Mathot… - … Journal of Cancer, 2024 - europepmc.org
Rectal cancer poses challenges in preoperative treatment response, with up to 30%
achieving a complete response (CR). Personalized treatment relies on accurate …
achieving a complete response (CR). Personalized treatment relies on accurate …
[PDF][PDF] Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer
K Hammarström, L Nunes, L Mathot, A Mezheyeuski… - 2024 - researchgate.net
Rectal cancer poses challenges in preoperative treatment response, with up to 30%
achieving a complete response (CR). Personalized treatment relies on accurate …
achieving a complete response (CR). Personalized treatment relies on accurate …
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo) radiotherapy, survival and recurrence risk in rectal cancer
K Hammarström, L Nunes, L Mathot… - International Journal of …, 2024 - infona.pl
Rectal cancer poses challenges in preoperative treatment response, with up to 30%
achieving a complete response (CR). Personalized treatment relies on accurate …
achieving a complete response (CR). Personalized treatment relies on accurate …